Table 1. Pathological features and hormone receptor status of the cohort of primary breast carcinomas analysed during the ADAM10 investigation.
| Tumour characteristic | N | % |
|---|---|---|
|
Age (years) | ||
| ⩽50 | 40 | 34.2 |
| >50 | 77 | 65.8 |
| Unknown | 0 | 0.0 |
|
Tumour size (cm) | ||
| ⩽2 | 32 | 27.3 |
| >2 | 76 | 65.0 |
| Unknown | 9 | 7.7 |
|
Grade | ||
| 1 and 2 | 46 | 39.3 |
| 3 | 60 | 51.3 |
| Unknown | 11 | 9.4 |
|
Nodal status | ||
| Negative | 56 | 47.9 |
| Positive | 56 | 47.9 |
| Unknown | 5 | 4.2 |
|
ER status | ||
| Negative | 38 | 32.5 |
| Positive | 79 | 67.5 |
| Unknown | 0 | 0.0 |
|
HER2 status | ||
| Negative | 100 | 85.5 |
| Positive | 6 | 5.1 |
| Unknown | 11 | 9.4 |
|
Histological typea | ||
| Ductal (D) | 92 | 78.6 |
| Lobular (L) | 16 | 13.7 |
| D and L | 5 | 4.3 |
| Other | 0 | 0.0 |
| Unknown | 4 | 3.4 |
Abbreviation: ER, oestrogen receptor.
All tumours were infiltrating carcinomas. Ductal carcinoma in situ and lobular carcinoma in situ were excluded.